Emphysema Progression at CT by Deep Learning Predicts Functional Impairment and Mortality: Results from the COPDGene Study.
Sign Up to like & getrecommendations! Published in 2022 at "Radiology"
DOI: 10.1148/radiol.213054
Abstract: Background Visual assessment remains the standard for evaluating emphysema at CT; however, it is time consuming, is subjective, requires training, and is affected by variability that may limit sensitivity to longitudinal change. Purpose To evaluate… read more here.
Keywords: emphysema progression; copdgene study; progression; emphysema ... See more keywords
Clinical Trial of Losartan for Pulmonary Emphysema: Pulmonary Trials Cooperative LEEP Trial.
Sign Up to like & getrecommendations! Published in 2022 at "American journal of respiratory and critical care medicine"
DOI: 10.1164/rccm.202201-0206oc
Abstract: RATIONALE There are no pharmacologic agents that modify emphysema progression in patients with chronic obstructive pulmonary disease (COPD). OBJECTIVE Evaluate the efficacy of losartan, an angiotensin receptor blocker (ARB), to reduce emphysema progression. METHODS The… read more here.
Keywords: losartan; emphysema progression; emphysema; trial ... See more keywords